The Valley Desk

NCT03315143 · Interventional trial

Effect of Sotagliflozin on Cardiovascular and Renal Events in Participants With Type 2 Diabetes and Moderate Renal Impairment Who Are at Cardiovascular Risk

Overall registry status Terminated

Phase 3

Conditions Chronic Kidney Diseases, Heart Failure, Type 2 Diabetes Mellitus

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov